Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell TherapyChristine E. Brown, Behnam Badie, Anita Kurien et al.|New England Journal of Medicine|2016Cited by 1.8k
Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent GlioblastomaChristine E. Brown, Michael C. Jensen, Behnam Badie et al.|Clinical Cancer Research|2015Cited by 754
A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cellsXiuli Wang, Michael C. Jensen, Wen-Chung Chang et al.|Blood|2011Cited by 600
Antitransgene Rejection Responses Contribute to Attenuated Persistence of Adoptively Transferred CD20/CD19-Specific Chimeric Antigen Receptor Redirected T Cells in HumansMichael C. Jensen, Stephen J. Forman, Leslie Popplewell et al.|Biology of Blood and Marrow Transplantation|2010Cited by 522
T cells expressing CD123-specific chimeric antigen receptors exhibit specific cytolytic effector functions and antitumor effects against human acute myeloid leukemiaArmen Mardiros, Stephen J. Forman, Cédric Dos Santos et al.|Blood|2013Cited by 373